Looking for leads, investment insights, or competitive intelligence?
News about AbbVie
Fortune research partner Great Place to Work has released its 2019 list of the best workplaces in health care and biopharma.
A year's course of the blockbuster drug is $60,000, more than triple its initial 2012 price.
The average price increase is nearly three times the current U.S. inflation rate.
AbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endometriosis.